Posted by Peter S. on November 30, 2005, at 22:46:02
Just for your info:
TAMPA, Fla., Nov. 21 /PRNewswire/ -- Somerset Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Division of Psychopharmacologic Drugs has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of February 26, 2006 for EMSAMŪ (selegiline transdermal system), an investigational transdermal patch for the acute and maintenance treatment of major depressive disorder.
poster:Peter S.
thread:583964
URL: http://www.dr-bob.org/babble/20051126/msgs/583964.html